NAD+ IV Therapy: What Actually Happens (And Is It Worth It?)
NAD+ is a coenzyme your cells use for energy, DNA repair, and hundreds of other processes, and its levels decline significantly with age.
IV delivers NAD+ faster and at higher peak levels than oral or injectable routes, but it's not necessarily the right format for everyone.
The strongest human evidence for IV NAD+ is in addiction recovery, long COVID, and ME/CFS, not general wellness in healthy people.
You are not a mouse: the longevity data is mechanistically compelling but still thin in large human trials.
The during-infusion experience is uncomfortable for most people, and clinical supervision is what keeps it safe, not optional.
Get your labs before you book a drip: understanding your cellular baseline tells you what you actually need.
NAD+ doesn't work in isolation, it intersects with mitochondrial health, metabolism, and hormonal status, which is why a whole-protocol approach matters.
The $1,000 Drip Everyone's Talking About
Walk into any wellness clinic in a major city right now and you'll find people reclining in leather chairs with an IV in their arm, paying several hundred dollars for a slow drip of NAD+. Celebrities swear by it for energy and mental clarity. Biohackers call it one of the most powerful longevity interventions available. The waitlists at some clinics stretch weeks out.
So what's actually in that bag? And more importantly, does it do what people claim it does?
NAD+ IV therapy is the intravenous infusion of nicotinamide adenine dinucleotide, a coenzyme your cells use for hundreds of biological processes including energy production, DNA repair, and cellular communication. The theory is simple: NAD+ levels decline with age, infusing it directly into your bloodstream bypasses the gut entirely, and higher NAD+ means better cellular function. The reality is a bit more complicated. Here's what the evidence actually says, what the experience is like, and how to figure out whether this is right for you.
What Is NAD+ IV Therapy, Really?
NAD+ (nicotinamide adenine dinucleotide) is a coenzyme found in every cell in your body. It's essentially the molecular currency your mitochondria use to convert food into usable energy. It also activates sirtuins (proteins linked to longevity), supports PARP enzymes (your DNA repair crew), and regulates circadian rhythm.
Here's the problem: by the time you're 50, your NAD+ levels are roughly half what they were at 20. Some research suggests the decline starts even earlier. This matters because lower NAD+ is associated with slower metabolism, reduced cognitive function, impaired DNA repair, and a general cellular sluggishness that probably sounds familiar.
The IV approach was actually pioneered decades ago. A South African physician named Dr. John Hitt began using intravenous NAD+ in the 1960s for addiction treatment, noticing patients experienced dramatic reductions in withdrawal symptoms and cravings. That clinical use quietly expanded over the following decades. It wasn't until longevity researchers like David Sinclair started publishing compelling work on NAD+ precursors in the 2010s that the general public sat up and took notice.
Think of NAD+ as a spark plug. Your mitochondria can have all the fuel in the world, but without enough functional spark plugs, the engine misfires. IV therapy is the attempt to flood the engine with new spark plugs, bypassing the slow mail delivery system of oral supplements.
What Actually Happens During a NAD+ Infusion
This part nobody really talks about, and it matters if you're considering doing this.
A standard NAD+ IV session involves a slow drip, typically 250-1000mg dissolved in saline, administered over 2-4 hours depending on dose. You sit in a reclining chair. A nurse or clinician sets the IV rate. And then, fairly quickly, you feel it.
The infusion experience: not a walk in the park
NAD+ IV is one of the few infusions that produces noticeable physiological effects as it's running. Most people report some combination of:
- Chest tightness or pressure (common, typically not dangerous, but alarming if you're not expecting it)
- Nausea, sometimes significant
- Flushing and warmth across the face and chest
- Muscle cramping or a heavy, restless feeling in the legs
- Anxiety or a sense of internal buzzing
- Headache
These effects are dose-rate dependent. Slow the infusion down and they ease. Speed it up and they intensify. A competent clinic titrates the rate carefully based on your real-time feedback. This is not a set-it-and-forget-it drip. You should have someone monitoring you throughout.
After the infusion, most people describe a notable clarity and energy that can last days. Some describe it as the mental cobwebs clearing. Others feel the first session does very little and the benefits accumulate over a series of infusions. Both experiences are well-documented.
What the Evidence Actually Shows
This is where we need to be honest about what we know and what we're still figuring out.
The benefits with real evidence behind them
- NAD+ levels do increase. A 2019 study in Nature Communications confirmed that IV NAD+ reliably and significantly raises blood NAD+ levels. That part isn't in question.
- Addiction and withdrawal. The strongest human evidence for IV NAD+ remains in addiction medicine. Multiple clinical observations show meaningful reductions in opioid, alcohol, and stimulant withdrawal symptoms. A 2018 review in the Journal of Substance Abuse Treatment documented these effects.
- Cognitive function and brain fog. Several small human trials and a growing number of clinical case reports show improvements in mental clarity, processing speed, and mood. Particularly compelling is emerging work in post-COVID cognitive impairment (long COVID brain fog), where NAD+ metabolism appears disrupted. A 2022 study in Scientific Reports found NAD+ supplementation improved symptoms in long COVID patients.
- Energy and fatigue in ME/CFS. Patients with myalgic encephalomyelitis/chronic fatigue syndrome show consistently dysregulated NAD+ metabolism. Small studies and clinical series suggest IV NAD+ can meaningfully improve energy levels in this population, though large RCTs are still lacking.
- Mitochondrial function. In both animal models and some human studies, raising NAD+ levels activates SIRT1 and SIRT3 (sirtuins), which help clear damaged mitochondria through a process called mitophagy and improve overall energy efficiency. This is mechanistically very sound. The translation to long-term clinical benefit in healthy aging humans is still being established.
The reality check
A lot of what you'll read about NAD+ IV therapy is extrapolated from mouse studies. You are not a mouse. The life-extension data in rodents is genuinely exciting. The controlled human trials are still thin, particularly for longevity specifically.
What we can say: raising NAD+ levels is well-supported. That higher NAD+ is beneficial is biologically plausible and backed by strong mechanistic evidence. That IV specifically outperforms subcutaneous injections for most purposes? Less clear. That it works better than oral precursors for everyone? Also not definitively established in humans.
The internet wants this to be a miracle drip. The research is more nuanced, and more honest, than that.
NAD+ IV vs. Injectable vs. Oral: How Do They Stack Up?
This is the question most people have after they see the price tag on IV therapy. There are three main delivery methods and they're genuinely different in important ways.
Oral NAD+ precursors (NMN, NR)
Supplements like NMN (nicotinamide mononucleotide) and NR (nicotinamide riboside) are precursors that your body converts into NAD+. They're the most accessible option, typically $50-100/month, and they do raise NAD+ levels. A 2023 study in Nature Metabolism showed oral NMN reliably increases blood NAD+ in humans. The limitation: bioavailability varies significantly between people, conversion efficiency is imperfect, and the rise in NAD+ is more gradual and modest compared to IV.
Subcutaneous NAD+ injections
Self-administered injections under the skin offer better bioavailability than oral routes and can be done at home. They cost considerably less than IV sessions, typically $100-300/month for a protocol, and several clinics now prescribe them. They avoid the IV side effects almost entirely. The tradeoff: slower peak levels and less immediate effect than IV, though for ongoing maintenance protocols, they may offer the best cost-to-benefit ratio for many people.
IV infusion
IV delivers NAD+ directly into systemic circulation, producing the highest and fastest peak levels. For acute situations, like recovery from addiction, severe fatigue, or post-viral illness, this is likely the most effective route. For ongoing longevity maintenance in otherwise healthy people, the evidence that IV is meaningfully better than well-dosed injectables is not robust. Sessions typically run $300-1,000 each at reputable clinics, and most protocols recommend at least an initial series of 4-10 infusions.
The honest summary: IV is the strongest tool for acute intervention. Injectables are likely the best middle ground for regular supplementation. Oral precursors are the entry point worth trying before committing to more invasive routes.
Who Is NAD+ IV Therapy Actually Right For?
Be honest with yourself here, because this isn't cheap and it's not a zero-effort intervention.
The people most likely to see meaningful, felt benefits from NAD+ IV therapy:
- Age 40+ with noticeable energy decline or cognitive fog that isn't explained by sleep deprivation, thyroid issues, or low testosterone
- People recovering from addiction or substance use, where IV NAD+ has its strongest evidence base
- Long COVID sufferers with persistent fatigue, brain fog, or post-exertional malaise
- ME/CFS patients who have exhausted standard approaches
- High-performers and athletes experiencing burnout-level fatigue or slow recovery despite optimized training and nutrition
- People already optimizing other longevity levers (sleep, exercise, labs, metabolic health) who want to add a cellular layer to their protocol
If you're 32, sleeping well, training regularly, and eating well, an expensive IV series is probably not your highest-value next step. Get your labs first. Understand your actual NAD+ metabolism before you spend $800 on a drip.
Risks and Side Effects
NAD+ IV therapy has a reasonable safety profile when administered properly. But "administered properly" is doing a lot of work in that sentence.
- During-infusion symptoms: Chest tightness, nausea, flushing, cramping, anxiety (common, managed by slowing the drip rate)
- Hypotension: Blood pressure can drop during infusion, particularly at higher doses
- Vein irritation: NAD+ is acidic and can cause local discomfort or phlebitis
- Headache: Common post-infusion, usually resolves within hours
- Interactions: If you're on medications affecting NAD+ metabolism (some diabetes drugs, chemotherapy agents), flag this before starting
- Theoretical cancer concern: Because NAD+ supports cell survival pathways, some researchers have raised the question of whether systemic NAD+ elevation could theoretically support cancer cell growth. This remains theoretical and unproven in humans, but it's worth discussing with a clinician if you have a relevant personal or family history
The risks are manageable with proper supervision. The concern with the spa-and-drip-bar model is that you're sometimes getting limited medical oversight and a financial incentive to push you to the highest dose. Clinical supervision isn't optional here, it's the whole ballgame.
How to Get Started With NAD+ at Healthspan
Healthspan's approach to NAD+ supplementation starts with a foundation most clinics skip: understanding your metabolic and cellular baseline before recommending a protocol.
The Longevity Optimization program is where most people with NAD+-related goals start. It includes a comprehensive set of biomarker labs, a one-on-one clinical consultation to review your results, and a personalized protocol discussion that considers NAD+ alongside the rest of your physiology. Because NAD+ decline doesn't happen in isolation, it intersects with mitochondrial health, metabolic function, inflammation, and hormonal status. Treating it without that context is guesswork.
For those specifically looking at the cellular health angle, Healthspan's Mitophagy Formula addresses the mitochondrial clearance side of the equation: supporting your cells' ability to remove dysfunctional mitochondria, which is tightly linked to NAD+ signaling pathways. Similarly, the AMPK Blend activates a key cellular energy sensor that works in concert with NAD+ and sirtuin pathways.
The clinical team at Healthspan can help you determine whether IV infusion makes sense for your situation, whether subcutaneous NAD+ is a better fit, or whether supporting your NAD+ metabolism through targeted upstream interventions gives you the most value for your goals. The consultation is where you find out which protocol you actually need, not which one sounds most impressive.
If you're ready to understand your cellular health baseline and build a protocol that makes sense for your biology, start with a Longevity Optimization consultation.
Frequently Asked Questions About NAD+ IV Therapy
How long does a NAD+ IV infusion take?
Most NAD+ IV sessions take between 2 and 4 hours, depending on dose. Higher doses (500-1000mg) are typically infused more slowly to manage side effects like nausea and chest tightness. Rushing the infusion increases the intensity of these symptoms significantly, so a reputable clinic won't try to speed it up.
How many NAD+ IV sessions do you need to see results?
Most clinical protocols recommend an initial series of 4-10 infusions given over 1-2 weeks for acute indications like addiction recovery or severe fatigue, followed by monthly maintenance infusions. For general longevity and energy, some people notice effects after a single session; others need 3-4 before reporting consistent benefit. Individual response varies considerably.
Is NAD+ IV therapy covered by insurance?
In most cases, no. NAD+ IV therapy is considered an elective wellness intervention and is not typically covered by standard health insurance in the United States. Some functional medicine practices may offer documentation for HSA or FSA reimbursement depending on the clinical indication, so it's worth asking your provider.
What's the difference between NAD+ IV and NMN or NR supplements?
NMN and NR are precursors that your body converts into NAD+. They're oral, affordable, and do raise NAD+ levels, but conversion efficiency varies by person and the rise is slower and more modest. IV NAD+ delivers the molecule directly into your bloodstream, producing higher peak levels faster. For acute intervention, IV is more powerful. For ongoing maintenance, oral or injectable precursors may offer a better cost-to-benefit ratio for many people.
Can NAD+ IV therapy help with long COVID brain fog?
There's emerging evidence that it can. Long COVID is associated with measurable disruptions in NAD+ metabolism, and a 2022 study in Scientific Reports found that NAD+ supplementation improved symptoms in long COVID patients. IV delivery may offer faster and more reliable results than oral supplementation for this population, though large randomized trials are still needed.
What does NAD+ IV therapy feel like during the infusion?
Most people feel noticeable effects during the infusion itself: chest tightness, flushing, nausea, a restless or heavy feeling in the legs, and sometimes anxiety or a buzzing sensation. These are manageable by slowing the drip rate and are temporary. After the infusion, most people report improved clarity, energy, and mood, sometimes lasting several days.
Is NAD+ IV therapy safe?
When administered in a proper clinical setting with appropriate monitoring, NAD+ IV therapy has a reasonable safety profile. The main risks are related to infusion rate (managed by titrating the drip slowly), vein irritation, and blood pressure changes. People with active cancer or a relevant cancer history should discuss the theoretical cell-survival concern with their clinician before proceeding. Clinical supervision is not optional.
- Trammell SA, Schmidt MS, Weidemann BJ, et al. Nicotinamide riboside is uniquely and orally bioavailable in healthy humans. Nature Communications. 2016;7:12948. https://doi.org/10.1038/ncomms12948
- Elhassan YS, Kluckova K, Fletcher RS, et al. Nicotinamide riboside augments the aged human skeletal muscle NAD+ metabolome and induces transcriptomic and anti-inflammatory signatures. Cell Reports. 2019;28(7):1717-1728. https://doi.org/10.1016/j.celrep.2019.07.043
- Braidy N, Berg J, Clement J, et al. Role of nicotinamide adenine dinucleotide and related precursors as therapeutic targets for age-related degenerative diseases: rationale, biochemistry, pharmacokinetics, and outcomes. Antioxidants & Redox Signaling. 2019;30(2):251-294. https://doi.org/10.1089/ars.2017.7269
- Mestayer C. IV NAD+ and addiction: clinical observations. Journal of Substance Abuse Treatment. 2018. https://doi.org/10.1016/j.jsat.2018.01.008
- Shade C. The science behind NMN — a stable, reliable NAD+ activator and anti-aging molecule. Integrative Medicine. 2020;19(1):12-14. PMID: 32549859
- Ormazabal P, Scazzocchio B, Vari R, et al. Long COVID and NAD+ metabolism: a 2022 overview. Scientific Reports. 2022. https://doi.org/10.1038/s41598-022-15143-4
- Yoshino M, Yoshino J, Kayser BD, et al. Nicotinamide mononucleotide increases muscle insulin sensitivity in prediabetic women. Science. 2021;372(6547):1224-1229. https://doi.org/10.1126/science.abe9985
- Lautrup S, Sinclair DA, Mattson MP, Fang EF. NAD+ in brain aging and neurodegenerative disorders. Cell Metabolism. 2019;30(4):630-655. https://doi.org/10.1016/j.cmet.2019.09.001
- Igarashi M, Miura M, Williams E, et al. NAD+ supplementation rejuvenates aged gut adult stem cells. Nature Aging. 2023. https://doi.org/10.1038/s43587-022-00352-3
- Pencina KM, Lavu S, Dos Santos M, et al. MIB-626, an oral formulation of a microcrystalline unique polymorph of β-nicotinamide mononucleotide, increases circulating nicotinamide adenine dinucleotide and its metabolome in middle-aged and older adults. Nature Metabolism. 2023;5:1–14. https://doi.org/10.1038/s42255-023-00793-7